definiens: shall mean any intellectual property owned or controlled by GCLC as of the Effective Date ofthis Agreement relating to methods and tools for culturing or engineering NK Cells, NK Cells produced and/or reduced to practiceby such methods ( including NK Cells containing CARs and NK Cells with other receptor or marker modifications ), or the use ormanufacture thereof, NK Cell manufacturing and production methods or cryoformulation technologies ; or any such intellectualproperty invented or acquired by GCLC during the Term independent of this Agreement, which GCLC makes available to Artivafor purposes of performing the Services under this Agreement . For clarity, such GCLC Background IP shall include all patentsand patent applications listed in Exhibit E and any and all divisionals, continuations, continuations - in - part, reissues, renewals, substitutions, registrations, re - examinations, revalidations, extensions, supplementary protection certificates, and the like of anysuch patents and patent applications, and foreign equivalents of any of the foregoing